Patent Document ID: 20110312509
Application ID: 13220082
Patent Flag: 0

Claim One:
1. A method for screening for the presence of prostate cancer in a patient comprising: detecting within a patient sample a combination of three or more polynucleotides selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 7, SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, and SEQ ID NO. 13; comparing levels of the polynucleotides to a control sample taken from a control subject not having prostate cancer, wherein the patient sample and the control sample are of a same sample type; wherein decreased levels of the polynucleotides in the combination in the patient sample relative to the control sample; are indicative of prostate cancer.